Skip to main content
. 2021 Sep 15;7(10):2764–2776. doi: 10.1021/acsinfecdis.1c00322

Table 4. Examples of Deprioritized Targets for MalDA.

target name (abbreviation) Pf gene ID reason for deprioritization
N-myristoyl transferase (NMT) PF3D7_1412800 slow killer, challenges with selectivity compared to the human enzyme
P-type ATPase 4 (ATP4) PF3D7_1211900 multiple series under investigation in the drug discovery pipeline
plasmepsin X PF3D7_0808200 multiple series under investigation in the drug discovery pipeline
Niemann–Pick type C1-related protein (NCR1) PF3D7_0107500 resistance risk, slow rate of kill and single-stage efficacy
dihydrofolate reductase (DHFR) PF3D7_0417200 clinically approved inhibitor; resistant parasites widespread in the field
dihydroorotate dehydrogenase (DHODH) PF3D7_0603300 multiple chemotypes have been developed, and resistance can arise readily
phosphatidyl inositol 4-kinase (PI4K) PF3D7_0509800 multiple chemotypes have been developed, and resistance can arise readily